相关实验视频
Updated: Jun 20, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.1K
对食物过敏的生物疗法
Meng Chen1,2, Wenming Zhang1, Lisa Lee1
1From the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford University, Stanford, California, and.
Journal of food allergy
|July 18, 2024
概括
生物药物有望通过提高口服免疫疗法 (OIT) 的安全性和减少持续时间来改善食物过敏治疗. 研究探讨生物制剂和疫苗作为独立或联合疗法,以更好地管理食物过敏.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 食物过敏影响全球6-13%的人,构成严重的健康挑战.
- 口服免疫疗法 (OIT) 是有前途的,但有副作用和长时间治疗等局限性.
研究的目的:
- 探索生物制剂在提高食物过敏治疗的安全性和有效性方面的潜力.
- 审查目前对生物制剂和疫苗进行的调查,以对食物过敏进行管理.
主要方法:
- 对针对食物过敏关键分子的生物制剂的审查,包括抗IgE,抗IL-4Rα,抗IL-5,抗IL-5R和抗IL-33疗法.
- 对花生DNA等离子体疫苗的研究.
- 探索生物药物作为单疗法和辅助疗法与OIT.
主要成果:
- 几种生物药物正在为食物过敏治疗进行研究.
- 生物药的目的是提高OIT的安全性,减少治疗时间.
- 疫苗和生物制剂正在为单疗法和组合疗法进行探索.
结论:
- 生物药物为食物过敏治疗提供了一个有希望的未来,可能会增强OIT并提供有关疾病机制的见解.
- 精准医学方法,包括生物制剂,正在推进食物过敏护理.
- 对生物制剂和疫苗的进一步研究对于开发更安全,更有效的食物过敏治疗非常重要.
相关概念视频
Allergic Drug Reactions
830
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
830
Allergic Reactions
27.3K
Overview
27.3K
Tumor Immunotherapy
504
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
504
Hypersensitivities
573
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
573
Antibody Structure
59.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.8K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
127
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
127

